← Back to headlines
BridgeBio Downgraded by Raymond James Following Pfizer Drug's Loss of Exclusivity
BridgeBio has received a downgrade from Raymond James, attributed to the loss of exclusivity for Pfizer's drug Vyndamax.
26 May, 13:25 — 26 May, 13:25
Sources
Showing 1 of 1 sources
Related Stories
US Army Awards $2.2 Billion for Nuclear Microreactors at Five Bases
17m ago
Oil Prices Decline on Prospects of Diplomatic Talks to Ease Middle East Supply Disruptions
38m ago
FSSAI Issues Food Safety Notices to Premier Delhi Hotels Ahead of BRICS Summit
55m ago
South Korea Central Bank Raises Rates to 3%, Upgrades Growth Forecast
55m ago